European Assisted Surgery Market Set for Strong Expansion
By HospiMedica International staff writers
Posted on 06 May 2013
Significant cost and clinical benefits will boost adoption rates of image-guided and robot-assisted surgery systems in Western Europe. These are the latest findings of Frost & Sullivan (Frost, Mountain View, CA, USA), an international market research firm.Posted on 06 May 2013
Image-guided and robot-assisted surgeries have made successful inroads into the western European market, following manufacturer efforts focused on improving awareness on the advantages of both surgical approaches, including reduction in the length of hospital stay and better surgical outcomes. But while image-guided surgery is becoming well-established, robot-assisted surgery is slower in gaining acceptance in Western Europe, due to a large initial investment and lower reimbursement values, resulting in budget conscious hospitals reluctant in buying expensive equipment and manufacturer-specific consumables.
When both image-guided and robot-assisted systems are taken into account, overall higher market growth and revenues are shown, but spending cuts across the European Union healthcare sector remain a major cause for concern for manufacturers. On the other hand, Frost and Sullivan predict that rigorous marketing drives in the European region will further enhance the existing growth trend in procedure volumes, positively impacting sales of image-guided and robot-assisted surgery in the coming years.
“Market participants must demonstrate cost-effectiveness and improved clinical outcomes of their product offerings in order to fuel greater uptake,” said Beulah Devadason, a healthcare industry analyst at Frost & Sullivan.
Frost and Sullivan estimate that the image-guided and robot-assisted surgery markets in Western Europe will reach a market volume of USD 1,697.5 million in 2018.
Related Links:
Frost & Sullivan